치은비대에서 비외과적 치료의 효과 = The effect of non-surgical treatment in gingival enlargement

다국어 초록 (Multilingual Abstract)

Purpose: It is well recognized that gingival enlargement is induced by unwanted effect associated with three major drugs/drug groups - phenytoin, cyclosporine, and the calcium channel blockers. The present case report describes the effect and limitation of non-surgical treatment in gingival enlargement cases. Materials and methods: Three cases included 2 drug-influenced gingival enlargement patients and a idiopathic gingival fibromatosis patient. For the drug-influenced gingival enlargement patients, the medication was replaced with other medication. And then, all the patients were treated non-surgically. Results: Drug-influenced gingival enlargements had been reduced after non-surgical treatment and the results were well-maintained. In the idiopathic gingival fibromatosis case, non-surgical treatment resulted in only limited reduction of gingival enlargement, and surgical periodontal treatment was unavoidable. Conclusion: These case reports indicated that non-surgical periodontal treatment with change in medication was effective in the treatment of drug-influenced gingival enlargements. Non-surgical approach can be considered as the primary management to reduce the gingival enlargement. If non-surgical treatment encounters a limitation, surgical treatment should be considered.

참고문헌 (Reference)

1 김원경, "치주치료가 약물성 치은비대 환자의 치은두께에 미치는 효과에 관한 연구" 대한치주과학회 35 (35): 1109-1116, 2005

2 Lewis IK, "Use of medications with potential oral adverse drug interactions in community-dwelling elderly" 13 : 171-176, 1993

3 Mavrogiannis M, "The management of drug-induced gingival overgrowth" 33 : 433-439, 2006

4 Fu E, "The effect of plaque retention on cyclosprine-induced gingival overgrowth in rats" 68 : 92-98, 1997

5 Seymour RA, "The effect of a plaque control programme on the incidence and severity of cyclosporin- induced gingival changes" 18 : 107-110, 1991

6 Rees TD, "Systemic drugs as a risk factor for periodontal disease initiation and progression" 16 : 20-42, 1995

7 Nakou M, "Subgingival microflora associated with nifedipine-induced gingival overgrowth" 69 : 664-669, 1998

8 Ellis JS, "Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study" 70 : 63-67, 1999

9 Casetta I, "Phenytoin-induced gingival overgrowth: A community-based cross-sectional study in Ferrara, Italy" 16 : 296-303, 1997

10 Aimetti M, "Non-surgical periodontal treatment of cyclosporin A-induced gingival overgrowth: immunohistochemical results" 14 (14): 244-250, 2008

11 Hancock RH, "Nifedipine-induced gingival overgrowth" 19 : 12-14, 1992

12 Barak S, "Gingival hyperplasia caused by nifedipine: Histopathological findings" 58 : 639-642, 1987

13 Somacarrera ML, "Effectiveness of periodontal treatments on cyclosporine-induced gingival overgrowth in transplant patients" 183 : 89-94, 1997

14 Boltchi FE, "Cyclosporine A-induced gingival overgrowth: A comprehensie review" 30 : 775-783, 1999

15 Newman MG, "Carranzaʼs Clinical Periodontology, 10th ed" W.B. Saunders 373-390, 2006

16 "Academy report: Drug-associated gingival enlargement" 75 : 1424-1431, 2004